Search clinical trials for: intravitreal ranibizumab,

Total 1401 results

Novartis Pharmaceuticals

Completed

Head to Head Study of Anti-VEGF Treatment. (RELIANCE)

Age-related Macular Degeneration

China
Zhongshan Ophthalmic Center, Sun Yat-sen University

Completed

Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization (SMILE)

Choroidal Neovascularization

China
LEANDRO CABRAL ZACHARIAS
Novartis

Unknown

Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study

Glaucoma, Neovascular | Ranibizumab
Ain Shams University

Completed

New Concepts in Diabetic Macular Edema (DME) (DME)

Diabetes Mellitus, With Complications
Ameera Gamal Abdelhameed

Completed

Long Term Outcome of Intravitreal Ranibizumab for ROP

Retinopathy of Prematurity

Egypt
Minia University

Completed

Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema

Diabetic Macular Edema
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia (Brilliance)

Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)

China, India, Thailand, Hong Kong, Korea, Republic of, Philippines
Novartis

Completed

Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) (EXCITE)

Age Related Macular Degeneration

Switzerland
Ameera Gamal Abdelhameed

Completed

Intravitreal Ranibizumab in Recurrent ROP

Retinopathy of Prematurity

Egypt
Hoffmann-La Roche

Completed

A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)

Neovascular Age-Related Macular Degeneration

United States
Novartis Pharmaceuticals

Completed

Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME (SALUTE-D)

Diabetic Macular Edema

Turkey
Vista Klinik

Completed

Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD

Age Related Macular Degeneration | Choroidal Neovascularization

Switzerland
The Ludwig Boltzmann Institute of Retinology and...
Medical University of Graz; Medical University of Vienna; Medical University... and other collaborators

Unknown

Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration (MANTA)

Age Related Macular Degeneration

Austria
He Eye Hospital

Unknown

Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.

Macular Edema

China
Beijing Hospital

Completed

Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO

Branch Retinal Vein Occlusion | Ranibizumab | Laser Photocoagulation

China
Prof. Dr. Antonia M. Joussen
Charite University, Berlin, Germany

Terminated

Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab (DORO)

Macular Edema, Cystoid | Visual Acuity Reduced Transiently

Germany
Novartis Pharmaceuticals

Completed

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients (EXTEND II)

Age Related Macular Degeneration

China
Novartis

Completed

SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Age Related Macular Degeneration | Choroidal Neovascularization

Switzerland
Kyoto University, Graduate School of Medicine
Novartis

Unknown

Ranibizumab Treatment for Retinal Vein Occlusion

Macular Edema Due to BRVO/CRVO

Japan
Retina Associates of Kentucky
Genentech, Inc.

Unknown

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome (IVL for OHS)

Ocular Histoplasmosis Syndrome

United States
Hanscom, Thomas, M.D.
Genentech, Inc.

Completed

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab (RAVEN)

Central Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein Occlusion

United States
McGill University Health Centre/Research Institute...

Unknown

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

Macular Degeneration | Visual Acuity

Canada
Gangnam Severance Hospital
Novartis; Inje University; Severance Hospital; Konkuk University

Completed

Cytokeratin 8 Level in Age-related Macular Degeneration

Age-related Macular Degeneration

Korea, Republic of
University of Miami

Completed

Ranibizumab for the Inhibition of Neovascularization in Pterygia

Pterygium

United States
Vista Klinik

Completed

SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia

Age Related Macular Degeneration | Choroidal Neovascularization

Switzerland
Xinhua Hospital, Shanghai Jiao Tong University...
Novartis

Unknown

Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema

Diabetic Macular Edema | Proliferative Diabetic Retinopathy

China
Pusan National University Hospital
Novartis

Completed

Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab

Exudative Age-related Macular Degeneration

Korea, Republic of
Egyptian Biomedical Research Network

Completed

Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy

Diabetic Retinopathy | Visual Acuity | Ranibizumab | Subfoveal Choroidal Thickness | Intravitreal

Egypt
Aier School of Ophthalmology, Central South University

Unknown

Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy (RANTA)

Wet Macular Degeneration

China
Beijing Hospital

Completed

Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME

Diabetic Macular Edema

China
Università degli Studi di Brescia

Completed

Ranibizumab Plus Indomethacin

Macular Edema
Center for Eye Research Australia
Novartis Pharmaceuticals

Terminated

Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging

Macular Degeneration | Choroidal Neovascularization

Australia
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus (RETAIN)

Diabetic Macular Edema

Belgium, United Kingdom, Netherlands, Ireland, Switzerland, Italy, Hungary, France, Spain, Portugal, Poland, Czech Republic, Greece
Novartis

Completed

Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration

Age-Related Macular Degeneration (ARMD)

Switzerland
Novartis Pharmaceuticals

Withdrawn

CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab (CANARI)

Wet Age-related Macular Degeneration (Wet AMD)
Attila Vajas
Semmelweis University

Unknown

Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone (VITARM)

Diabetic Retinopathy

Hungary
Sun Yat-sen University

Unknown

Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab (IVRDME)

Diabetic Macular Edema

China
Oklahoma State University Center for Health Sciences

Completed

Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab

Choroidal Neovascularization

United States
Sun Yat-sen University

Completed

Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen

Polypoidal Choroidal Vasculopathy

China
Poitiers University Hospital

Completed

Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment

Diabetic Macular Edema

France
University Hospital, Basel, Switzerland

Completed

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

Age-Related Macular Degeneration | Choroidal Neovascularization

Switzerland
Cairo University

Unknown

Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.

Diabetic Macular Edema

Egypt
Novartis

Completed

A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study (RESTORE)

Diabetic Macular Edema

Greece, Belgium, Spain, France, Netherlands, Australia, Canada, Germany, Hungary, Italy, Switzerland, Turkey, United Kingdom
University of Illinois at Chicago
Genentech, Inc.

Withdrawn

Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

Angioid Streaks
The New York Eye Cancer Center
Genentech, Inc.

Completed

Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma

Radiation Retinopathy | Choroidal Melanoma

United States
Uludag University

Completed

The Effect of Ranibizumab on Eye Lens Opacity in Cases With Age-Related Macular Degeneration

Age-Related Macular Degeneration | Cataract

Turkey
Centro Hospitalar do Porto

Completed

Effect of the Vitreous in Response to Intravitreal Injections of Ranibizumab for the Treatment of Diabetic Macular Edema (DEVITRA)

Diabetic Macular Edema

Portugal
Instituto de Olhos de Goiania

Completed

Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis

Glaucoma | Rubeosis Iridis

Brazil
Hoffmann-La Roche

Active, not recruiting

This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Participants With Diabetic Macular Edema Compared With Intravitreal Ranibizumab (Pagoda)

Diabetic Macular Edema

United States
Novartis Pharmaceuticals

Completed

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE) (PRIDE)

Proliferative Diabetic Retinopathy (PDR)

Germany

3

Subscribe